ETC
MGNX icon

Exchange Traded Concepts’s MacroGenics MGNX Stock Holding History

Exchange Traded Concepts’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,434
Closed -$74.2K – 1473
2025
Q1 		$74.2K Buy
58,434
+9,611
+20% +$25.1K ﹤0.01% 1209
2024
Q4 		$159K Hold
48,823
– – ﹤0.01% 1038
2024
Q3 		$161K Buy
48,823
+35,291
+261% +$137K ﹤0.01% 1039
2024
Q2 		$57.5K Sell
13,532
-4,210
-24% -$41K ﹤0.01% 978
2024
Q1 		$261K Sell
17,742
-12,343
-41% -$187K 0.01% 851
2023
Q4 		$289K Buy
30,085
+7,629
+34% +$52.7K 0.01% 755
2023
Q3 		$105K Sell
22,456
-1,078
-5% -$5.37K ﹤0.01% 877
2023
Q2 		$126K Buy
+23,534
New +$145K ﹤0.01% 893

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Exchange Traded Concepts's MGNX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 58,434 shares — an estimated $74.2K sold.

Exchange Traded Concepts first reported a position in MGNX in Q2 2023 and held it in 8 quarters. The position peaked at $289K in Q4 2023. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 58,434 MacroGenics shares in Q2 2025, an estimated $74.2K.
  • Exchange Traded Concepts first reported a position in MacroGenics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's MacroGenics position peaked at $289K in Q4 2023.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.